Eli Lilly today announced a $4.5 billion investment to create the Lilly Medicine Foundry, a new center for advanced ...

Swiss biotech Nuclidium is gaining attention for its copper-based radioligand therapeutics and diagnostics, capitalizing on ...

Johnson & Johnson today released results of a landmark real-world head-to-head study showing that Erleada (apalutamide) ...

August was a quiet month for pharma dealmaking, with few major acquisitions from industry giants. Notably, Organon agreed to ...

The BioIndustry Association (BIA) and Centre for Process Innovation (CPI) have published a report highlighting the UK's mRNA ...

US antivirals giant Gilead Sciences today announced that it has signed non-exclusive, royalty-free voluntary licensing ...

Ferring Pharmaceuticals reported positive results from the OPTIMISE study, showing that a treat-to-target approach using ...

Privately-held UK biotech Curve Therapeutics today announced the further strengthening of its leadership team with the ...

Shattuck Labs is reducing its workforce by 40%, bringing its employee count below 50, and discontinuing its SL-172154 program ...

UK-based biotech LoQus23 Therapeutics has raised £35 million ($43 million) in a Series A financing round led by Forbion, with ...

The US Food and Drug Administration (FDA) yesterday released its fiscal year 2023 (FY23) Generic Drug User Fee Amendments ...

Early Access Programs (EAPs) and Named Patient Programs (NPPs) provide a pathway for patients with life-threatening ...